Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novozymes A/S    NZYM B   DK0060336014

NOVOZYMES A/S (NZYM B)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Copenhagen
07/13/2018 07/16/2018 07/17/2018 07/18/2018 07/19/2018 Date
331(c) 331.4(c) 333.3(c) 334.9(c) 334.7 Last
258 863 166 281 252 860 337 734 71 815 Volume
-0.03% +0.12% +0.57% +0.48% -0.06% Change
More quotes
Financials (DKK)
Sales 2018 14 391 M
EBIT 2018 4 080 M
Net income 2018 3 180 M
Debt 2018 2 235 M
Yield 2018 1,49%
Sales 2019 15 249 M
EBIT 2019 4 343 M
Net income 2019 3 395 M
Debt 2019 2 526 M
Yield 2019 1,65%
P/E ratio 2018 30,77
P/E ratio 2019 28,37
EV / Sales2018 5,82x
EV / Sales2019 5,51x
Capitalization 81 455 M
More Financials
Company
Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms.Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions.The... 
Sector
Commodity Chemicals
Calendar
08/10 | 08:00amEarnings Release
More about the company
Surperformance© ratings of Novozymes A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVOZYMES A/S
07/18NOVO NORDISK A/S : Vattenfall Signs New Offshore Wind Power Agreement
AQ
07/17NOVO NORDISK A/S : Vattenfall, Novozymes and Novo Nordisk sign a long term Power..
AQ
07/17NOVO NORDISK A/S : Novozymes and Novo Nordisk sign long-term PPA with Vattenfall
AQ
07/14NOVO NORDISK A/S : Vattenfall, Novozymes, Novo Nordisk Sign Long Term Power Purc..
AQ
07/14NOVOZYMES A/S : and Novo Nordisk sign deal to source power from Denmarks largest..
AQ
07/13NOVO NORDISK A/S : Vattenfall inks power deal with Novo Nordisk, Novozymes
AQ
07/13Vattenfall Signs Wind-Energy Deal With Novo Nordisk, Novozymes
DJ
07/13NOVO NORDISK A/S : Vattenfall, Novozymes and Novo Nordisk sign a long term Power..
AQ
07/09NOVOZYMES A/S : Transactions under Novozymes’ stock buyback program
AQ
06/25NOVOZYMES A/S : Transactions under Novozymes’ stock buyback program
AQ
More news
Sector news : Commodity Chemicals - NEC
08:02aSOLVAY : Signs Supply Agreement with Safran for LEAP Aircraft Engine
DJ
07:49aSAUDI BASIC INDUSTRIES SJSC : Aramco in talks for stake in world's no. 4 chemica..
RE
07/18EXCLUSIVE : Saudi Aramco mulls stake in world's no. 4 chemical firm: sources
RE
07/18EXCLUSIVE - SAUDI ARAMCO MULLS STAKE : sources
RE
07/18AKZONOBEL : Akzo Nobel misses second-quarter core earnings, sales forecasts
RE
More sector news : Commodity Chemicals - NEC
Latest Tweets
07/13Novozymes and Novo Nordisk sign deal to source power from Denmark’s largest w..
7
07/13Vattenfall Signs Wind-Energy Deal With Novo Nordisk, Novozymes  
07/13Vattenfall, Novozymes and Novo Nordisk sign a long term Power Purchase Agreem.. 
05/17Global Yeast & Enzymes Procurement Market Intelligence Report 2018 - Top .. 
05/02Novozymes A/S : Trading by management and close relations of management  
More tweets
Qtime:27
News from SeekingAlpha
06/22Treasure Hunting In The OTC Market 
06/18INTERNATIONAL FLAVORS & FRAGRANCES : That Taste In Your Mouth - Bitter Or Sweet? 
05/30Value Hunting Overseas 
04/29Novozymes' (NVZMF) CEO Peder Holk Nielsen on Q1 2018 Results - Earnings Call .. 
04/26Novozymes A/S 2018 Q1 - Results - Earnings Call Slides 
Chart NOVOZYMES A/S
Duration : Period :
Novozymes A/S Technical Analysis Chart | NZYM B | DK0060336014 | 4-Traders
Technical analysis trends NOVOZYMES A/S
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 311  DKK
Spread / Average Target -7,1%
EPS Revisions
Managers
NameTitle
Peder Holk Nielsen President & Chief Executive Officer
Jørgen Buhl Rasmussen Chairman
Thomas Videbaek COO, Executive VP-Research, Innovation & Supply
Prisca Havranek-Kosicek Chief Financial Officer & Executive Vice President
Carl Erik Mathias Uhlén Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
NOVOZYMES A/S-5.53%12 656
SAUDI BASIC INDUSTRIES CORPORATION SJSC--.--%102 731
AIR LIQUIDE5.52%54 597
PRAXAIR6.69%47 950
LYONDELLBASELL INDUSTRIES-1.55%42 387
SHIN-ETSU CHEMICAL CO LTD-11.59%39 362